Abstracts Brochure - CERN

WEPCH157
WEPCH158
WEPCH159
28-Jun-06 16:00 - 18:00 WEPCH — Poster Session
system which used obsolete technology and operator devices. The new system is in operation since 2005 and 2/3 of
all alarm equipement on the CERN sites are now handled by the new system. The migration/installation process is
is expected to terminate in May 2006. This paper presents the system architecture, the deployment process and the
return of experience in the accelerator environment.
Design and Beam Dynamics Simulation for the Ion-injector of the Austrian Hadron Therapy
Accelerator
MedAustron is an initiative for the construc-
Th. Strodl (ATI)
tion of the Austrian Hadron Therapy Centre.
In 2004 the design study was presented. The
basic design consists of two ion sources, an ion-injector, a synchrotron and a beam transfer line with five possible beam
exits. The synchrotron is based on the proton ion medical machine study (PIMMS) design with some modifications.
The injector is based on the GSI design of the Heidelberg ion therapy cancer accelerator with the original radio
frequency quadrupole and IH-Linac. Modifications have been done in the design of the low energy beam transport
and the medium energy beam transport lines. The impact of these modifications has been investigated, and several
other beam scenarios have bean simulated with different simulation codes.
Status of the hadrontherapy ETOILE-Project in Lyon
The ETOILE project is the French program
M.J. Bajard (UCBL)
for carbon ion beams in cancer treatment. It
is now in the final phase. However its development
is not only aiming at the building of a medical facility, around the project a broad set of medical and
scientific programs have been initiated. The project has been supported by the University of Lyon and extended to
the Rhône-Alpes Region and then gained a national visibility with governmental recognition. Many studies have
been financed by ETOILE: in beam PET with new solutions, organ motion modelization, tumor cell radioresistance,
medico-economical simulation and epidemiological previsions. The facility will be able to produce carbon ion beams
and protons. Three treatment rooms are planned, two with horizontal beams and one with an isocentric gantry. The
facility will be build in Lyon, through a process using as much as possible well established technology with the other
facilities in Europe. The cost will be around 105 MŁ afforded by loans and subventions. The subventions are funded
from the Rhône-Alpes Region, the city of Lyon and the ministries of Health and Research. The running cost of the
centre, for one thousand patients per year, is estimated to be 21 MŁ.
Accelerator Systems for Particle Therapy
S.P. Møller, A. Elkjaer, N. Hauge, L.H. Helmersen, T. Holst, I.
Jensen, S.M. Madsen (Danfysik A/S) K. Blasche, B. Franczak (GSI)
S. Emhofer, H.K. Kerscher, V.L. Lazarev, H. Rohdjess (Siemens AG,
Medical Solutions)
318
Danfysik and Siemens have entered a cooperation
to market and build Particle Therapy*
systems for cancer therapy. The systems are
based on the experience from GSI together
with a novel design of a synchrotron and
Siemens experience in oncology. The accel-
erator systems will include an injector system (7 MeV/u proton and light ions), a synchrotron and a choice of fixedangle
horizontal and semi-vertical beamlines together with gantry systems. The slowly extracted beam will cover the